The first anti-diarrheal drug for HIV /AIDS patients has been approved by the FDA for use in the United States. Fulyzag (crofelemer) has been approved to relieve symptoms of diarrhea in HIV / AIDS ...
Benefits include ulcer inhibition, anti-angiogenic qualities, renal protection, anti-diarrheal effects, anti-inflammatory and analgesic potentials, anti-diabetic effects, and anti-depressant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback